 This statistic reveals the revenues generated by biotech company Celgene's top products between 2013 and 2018. In 2014, one of the company's top products, Otezla, generated revenues of around 70 million U.S. dollars. Otezla's annual revenue increased up to 1.6 billion dollars until 2018. Celgene Corporation is headquartered in Summit, New Jersey. The company is specialized on drug manufacturing for cancer and inflammatory disorders. 